FABP2 and susceptibility to pneumonia measurement: These findings are in line with a study conducted by Guedj et al. (29), where the investigators compared plasma I-FABP levels in COVID-19 patients with pneumonia to patients who had pulmonary disease but not COVID-19 and to patients with abdominal pain but not COVID-19.